Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance
S. Alireza Rabi(Johns Hopkins University), Robert F. Siliciano(Howard Hughes Medical Institute), Liang Shan(National Center for Biotechnology Information), Stanley Chioma(Howard Hughes Medical Institute), Christine M. Durand(University of Maryland, Baltimore), Sarah B. Laskey(Johns Hopkins University), Richard D. Moore(Johns Hopkins University), Gregory M. Laird(Duke Medical Center), Justin R. Bailey(Johns Hopkins University)
Cited by 140
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Lipidomics reveals a remarkable diversity of lipids in human plasma
|Journal of Lipid Research|2010|1.3k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Defective proviruses rapidly accumulate during acute HIV-1 infection
|Nature Medicine|2016|774